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IntroductIon
Recurrent pregnancy loss (RPL) constitutes a chal-
lenge in the field of reproductive medicine as the 
etiology, in approximately 50% of cases of RPL, re-
mains unknown. It has been assumed that immune 
cause is associated with RPL, with few a v a i l a b l e 
evidence-based diagnostic and treatment guidelines. 
The etiology of RPL is considered complicated, sub-
divided into embryological (mainly due to an ab-
normal embryonic karyotype) and maternal causes, 
affecting the endometrium and/or placental develop-
ment (coagulation disorders, autoimmune defects, en-
docrine disorders and endometrial defects).
Various alterations take place in the maternal 
immunity system during gestation,  ensuring the 
protection of the semi-allogenic fetus and the main-
tenance of pregnancy. More specifically, Human Leu-
kocyte Antigen (HLA) gene expression status, lym-
phocyte populations and complement proteins are 
all submitted to specific changes in order a possible 
abortion to be avoided. It seems that trophoblast cells 
control monocyte migration and differentiation,  pro-
ducing a pro-inflammatory cytokine and chemokine 
profile, essential for their survival and growth1. 
The attack of maternal immune cells against pater-
nal HLA class 1 antigens can be prevented by regu-
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lating firmly the expression of specific HLA class 1 
molecules in subpopulations of trophoblasts2. The 
extravillous trophoblasts migrating into the deciduas 
display a unique pattern of HLA class 1b mole-
cules, with HLA-E, F and G predominating. HLA-G 
activates different pathways in uterine NK cells and 
macrophages and alters their killer function by in-
teracting with leukocyte inhibitory receptors (LIR’s) 
on uterine natural killer cells (uNK) and macrophages 
and with the T cell receptor on CD8+ (Cluster of 
Differentiation) cells3,4. HLA-G expression in anti-
gen presenting cells suppress T-cell proliferation, via 
apoptosis5). Polymorphism and methyliosis of HLA-
G antigen are associated with recurrent pregnancy 
loss6,7. Moreover, sted thatHLA-G is not involved in 
T-cell suppression exclusively with its membrane-
bound form, but also with a soluble isoform in ma-
ternal serum8,9,10,11. 
Regarding macrophages, their collaboration with 
trophoblast promotes the normal forming of placenta 
by enabling vascular remodeling and tissue homeo-
stasis12. Decidual CD68+ cells (macrophages) excrete 
immunosuppressive agents (Prostaglandin E2), and 
downregulate inflammatory responses at the feto-
maternal interface that help to prevent some uterine 
infections in pregnant women. The quick and effec-
tive removal of apoptotic cells by tissue macrophages 
prevents the release of self-antigens, and in the case of 
pregnancy, paternal alloantigens13.
Our aim was to examine the immune profile of 
women with recurrent pregnancy loss of unknown eti-
ology, during first trimester of their pregnancy, using 
immunological markers for CD68 factor as well as 
the HLAG expression in two groups of decidual 
tissues. 
MAterIALS And MetHodS
The miscarriage group was obtained from 25 women, 
between the ages of 35 to 42 years, who miscarried 
during the 1st trimester of gestation and controls con-
sisted of 25 healthy women, between the ages of 27 to 
39 years, who had electively terminated their pregnan-
cies, during the 1st trimester of gestation. All samples 
were collected after obtaining informed consent from 
patients. All 25 women from the miscarriage group 
had a history of at least three prior first trimester mis-
carriages of unexplained aetiology (normal parental 
karyotypes, intrauterine structural study, luteal phase 
endometrial biopsy, hormone concentrations and neg-
ative cervical cultures, lupus anticoagulant and anti-
bodies to cardiolipin and phosphatidyl serine).
Pathology-examination
Tissues
Tissues were collected, immediately after miscar riage 
or elective abortion and washed with distilled water 
for removal of mucus and blood, then, were studied 
under stereomicroscope, so that tissues from decidua, 
villus chorion and parts of the embryo, could be dis-
tinguished and examined for formation abnormalities 
or placental lesions. Specimens were collected from 
the above stabilized in aqueous solution that consisted 
of neutral formalin 10% v/v for 12-24 hours and then 
were placed in automatic machine for further process-
ing, including fixation, dehydration, xylene clarifica-
tion and paraffin embedding. Then, sections in 3-5 
mm transferred to positive charged and properly pre-
pared glass plates, which were kept in an oven, at 37-
40°C for 30-45 min. After this step, specimens were 
stained with haematoxylin-eo sin solution (Harris) and 
the most suitable of them were selected for immuno-
histochemical study. 
Immunohistochemistry
In all specimens, decidua basalis was identified us-
ing the antibody cytokeratin (CK7), which is posi-
tive in trophoblastic cells (Figure 1). Furthermore, 
for the discrimination between decidual and tropho-
blastic cells at the fetomaternal interface, duplicate 
sections were stained with a monoclonal antibody 
against prolactin, for the visualization of decidual 
cells (Figure 2).
The unstained specimens were further processed 
using an automatic machine (Bond Max) that carried 
out the following procedures. First, deparaffiniza-
tion was performed in xylene. Afterwards, specimens 
were immersed in absolute alcohol, in decreasing 
concentration 100%, 96% and 70% v/v consecu-
tively and were rinsed with distilled water. Antigen 
retrieval was performed by incubation in various 
temperatures, depending on the antibody that was 
examined each time.
Following this procedure, specimens were at first 
rinsed with PBS buffer, then incubated in H2O2 for 
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5 min, to quench endogenous peroxidase activity 
and finally rinsed again with PBS buffer. There-
after, specimens were covered with a solution of 
the primary tonic monoclonal antibody, one of 
the five used in our study. These antibodies as men-
tioned above are: HLAG (clone MEM-G/2: sc-51676, 
Santa Cruz Biotechnology, Inc USA), CD68 (clone 
514H12, Catalog No: PA0273, Leica Microsystems 
UK). Eventually, specimens were washed using WAS 
solution.
For the detection of the immunohistochemical 
staining, specimens were firstly immersed in Post-
Primary solution. After being washed off specimens 
were immersed in Polymere solution and then in chro-
mogen diaminobenzidine (DAB) solution. Finally, 
specimens were stained with Haematoxylin- eosin. 
Following the previous stages that were performed 
by the automatic processor, specimens were rinsed 
in tap water and dehydrated with escalating densities 
of ethanol solution (70, 96 and 100% v/v consecu-
tively) and xylene. Then, they were covered with 
tape, placed in glass plates and immersed in Canada 
balsam.
The previously reported immunohistochemical 
staining procedure was repeated for each of the 2 
antibodies that were examined in this study. The 
monoclonal antibody f o r  CD68 was already set and 
ready to be used, while the monoclonal antibody 
for HLAG needed to be in dilution 1:50 correspond-
ingly.
Microscopic evaluation was performed to the 
cells of the intermediate trophoblast on decidua ba-
salis and decidua parietalis of recurrent miscarriage 
and elective abortion material. Specimens were 
examined using an optical ZeissTM microscope and 
photographs were taken using a ContaxTM camera, 
attached to the microscope. Totally, 100 specimens 
(50 from the implantation site and 50 from desidua) 
were examined. Intensity of staining was evaluated 
as negative (-), weak (+), moderate (++) and strong 
(+++). Finally, the results were statistically analysed 
and checked for their significance using the Mann-
Whitney test.
reSuLtS
Regarding the immunohistochemical staining for CD-
68 cells, all sections (n = 25) of decidua basalis in 
control group were found negative (-) (Figure 3a). In 
contrast, the staining for CD-68 cells was detected 
positive in all sections (100%) of decidua basalis in 
miscarriage group (Figure 3b). Specially, 3 out of 25 
(12%) sections of miscarriage group presented mod-
erate (++) staining, with the rest of them (88%) to 
be strong positive (+++) (Figure 3b). Observing the 
sections of decidua parietalis of control group, CD68 
cells were not identified in none of them (0%). On the 
contrary, intensity of immunohistochemical staining 
for CD-68 cells on decidua parietalis of women from 
miscarriage group was detected moderate (++) in all 
sections (n = 25). It’s obvious the statistical significant 
Figure 1. Control group. Decidua Basalis. CK7. Detection 
of trophoblastic cells. x16.
Figure 2. Decidua basalis. Prolactin detection in decidual 
cells. X160.
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difference between miscarriage and control group, in 
regards to inflitration of CD-68 cells in both basalis 
and parietalis decidua (p < 0.05) (Table 1).
Regarding immunohistochemical staining for 
HLA-G antibody in sections of decidual basalis, 
there  was  s ta t i s t ica l  s ignif icant  d i fference 
between control  and miscarr iage  group.  All 
sections (n = 25) of decidua basalis in control 
group were found w e a k  p o s i t i v e  (+) (Figure 4a), 
while all sections in miscarriage group were negative 
(-) (Figure 4b). As for the sections from decidua pari-
etalis, in both control and miscarriage group HLA-G 
antibodies were not found (Table 1).
dIScuSSIon
Based on the results of our study, the immunologi-
cal profile of women with recurrent pregnancy loss 
is quite different, comparing with that of controls. 
It seems that recurrent pregnancy loss syndrome is 
provoked by a ‘malfunction’ of the immunity sys-
tem, which fails to protect the fetus. Previous reports 
concerning this syndrome, seem to support such an 
hypothesis, as they also detect alterations of the rela-
tive populations of the immunity cells in deciduas in 
contrast with controls. 
It is known the role of macrophages (CD 68+ 
cells) in formation of feto-maternal interface. Pre-
Figure 3. Staining for CD68+ cells in Decidua Basalis. a. Control group. Negative (-), x16. b. Miscarriage group. Strong 
(+++) intensity, x16.
Figure 4. Staining for HLA-G in Decidua Basalis. x16. a. Control group. Weak (+) intensity. b. Miscarriage group. Negative 
(-) intensityClinical Skills Teaching in AUTH Medical School.ϲ.
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vious studies highlight that macrophages, in human 
uterus, participate in apoptotic cell phagocytosis13, 
interact with trophoblast to perform vascular remod-
eling in the uterus14, increase monocyte migration at 
decidua basalis and induce a significant increase in 
the secretion and production of the pro-inflammatory 
cytokines and chemokines1. In our study, we detected 
a significant increase of CD68+ cell expression in 
both decidua basalis and parietalis of women with re-
current miscarriage, in contrast with controls. Based 
on the available reports, the number of macrophages 
in decidua of women with recurrent pregnancy loss 
seems to be similar with normal population15. An in-
crease in macrophage population was observed only 
in non pregnant endometrium of women with recur-
rent miscarriage. Our research suggests a possible 
involvement of CD68+ cells in recurrent pregnancy 
loss pathophysiology. 
HLA-G expression in antigen-presenting cells 
suppress T-cell proliferation and alters the killer func-
tion of uterine macrophages and NK cells, protect-
ing the semi-allogenic fetus3,4,5. In our study, HLA-G 
expression was found decreased in decidua parietalis 
of women with RPL in comparison with women with 
elective abortions (control group). In decidua basalis, 
in both groups, HLA-G expression was found invari-
able. Our results,  are in accordance with the relative 
previous reports, which claims that in decidua from 
women with recurrent miscarriage an increased NK 
cell marker expression of both CD56 and CD16 was 
accompanied by a decreased expression of HLA-G16. 
However, our conclusions should be interpreted with 
caution, as other reports support that HLA class 1b 
antigens, HLA-E, HLA-F, and HLA-G, are detectable 
only on some subpopulations of trophoblast17,18,19, 
20,21. In the same direction, Bhalla (2006) stated that 
HLA-G is expressed only in the extravillous tropho-
blast and there is no significant difference in expres-
sion pattern between the recurrent miscarriage and 
the control group22.
Although the immunity system cells and their fac-
tors seem to involve actively on feta-maternal inter-
face disorganization and unexplained recurrent preg-
nancy loss, a lot of research is yet needed in order to 
decrypt fully the multifactor etiology of this clinical 
entity.
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table 1. Intensity of staining for immunological cell markers in decidual tissues from miscarriage group and control group.
Miscarriage Group control Group Miscarriage Group control Group
cd68 Decidua Basalis Decidua Basalis p Decidua Parietalis Decidua Parietalis p
(-) 0(0%) 25(100%) < 0.05 0(0%) 25(100%) < 0.05
(+) 0(0%) 0(0%) 0(0%) 0(0%)
(++) 3(12%) 0(0%)
< 0.05
25(100%) 0(0%) < 0.05
(+++) 22(88%) 0(0%) 0(0%) 0(0%)
HLA-G
(-) 25(100%) 0(0%) < 0.05 25(100%) 25(100%)
(+) 0(0%) 25(100%) < 0.05 0(0%) 0(0%)
(++) 0(0%) 0(0%) 0(0%) 0(0%)
(+++) 0(0%) 0(0%) 0(0%) 0(0%)
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